Europe Addiction Treatment Market

Europe Addiction Treatment Market Size (2024 to 2029)

The addiction treatment market in Europe is estimated to be valued at USD 4.05 billion by 2029 from USD 3.14  billion in 2024, growing at a CAGR of 5.26% from 2024 to 2029.

The growing consumption of cigarettes and illegal drugs is one of the major factors propelling the addiction treatment market in Europe.

According to a recent survey, 29% of adults in the European region use illegal drugs at least once in their lifetime. Cannabis is the most consumed drug by European adults. In addition, the growing consumption levels of alcohol are another notable factor accelerating the market growth in the European region. An estimated 2 million adults aged between 18-64 in Europe consume frequently, and around 70,000 every year dies due to excessive consumption of alcohol in the European region. The excessive consumption of alcohol also leads to the diagnosis of various diseases among the European population, resulting in severe psychosocial impacts. To reduce the mortality rate from alcohol, the governments of European countries have been taking several measures and investing considerably to develop treatment methods and drugs to prevent alcohol addiction in the European region. Such factors are anticipated to fuel the growth rate of the European addiction treatment market.

The growing R&D activities to develop effective drugs are contributing to the growth of the European addiction treatment market. Many pharmaceutical companies in the European region invest in the R&D and production of drugs related to addiction. Furthermore, an increasing number of favorable reimbursement policies favor regional market growth.

However, poor awareness among the European population regarding the treatment options for addictions is majorly hampering European market growth. Furthermore, the unavailability of treatment centers in rural areas further hinders the regional market growth. In addition, the reluctance of people to use drug treatment for addiction is impeding the addiction treatment market growth in Europe.

This research report on the European addiction treatment market has been segmented and sub-segmented into the following categories.

Europe Addiction Treatment Market Analysis By Treatment Type

• Tobacco/Nicotine
• Opioid
• Alcohol
• Other Substance

Europe Addiction Treatment Market Analysis By Drug Type

• Bupropion
• Varenicline
• Acamprosate
• Buprenorphine
• Disulfiram
• Methadone
• Naltrexone
• Nicotine Replacement Products
• Others

Europe Addiction Treatment Market Analysis By Treatment Centre

• Outpatient
• Inpatient
• Residential

Europe Addiction Treatment Market Analysis By Distribution Channel

• Hospital Pharmacies

• Medical Stores

• Others

Europe Addiction Treatment Market Analysis By Country

• UK

• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The European region occupied a considerable share of the worldwide market in 2023 and is anticipated to showcase a promising CAGR during the forecast period. Factors such as the growing number of clinics for addiction treatment and increasing awareness among people regarding addiction treatment to lead a quality life are promoting market growth in Europe. In 2022, Broadway Lodge, a residential treatment center used for addiction treatment located in Weston-Super-Mare, received European Awards in medicine.

The German addiction treatment market is anticipated to hold a major share of the European market during the forecast period.

The growing number of addiction drug approvals is one of the major factors promoting the German market growth. In addition, the growing focus of the German government to develop various ways to reduce the number of people suffering from addictions is favoring market growth. Germany has many addiction research centers for children and adolescents to provide the best prevention methods or drugs for fast cures.

The UK had a considerable share of the European market in 2023. During the forecast period, the UK market is expected to showcase a prominent CAGR owing to the growing number of rehabilitation centers. The consumption of drugs and alcohol has been growing considerably in the last few years in the UK, resulting in many programs to help people join rehabilitation centers. Rehabilitation centers provide an excellent environment to reduce or stop the use of alcohol or drug usage. Additionally, increasing awareness programs and advertisements in social media and television also helps to know about the additional treatment or drugs for uneducated people to get out of it.

KEY MARKET PLAYERS

Pfizer Inc., Mallinckrodt, Orexo AB, Indivor Plc, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Cipla Ltd., Alkermes Plc, Hikma Pharmaceuticals PLC, Titan Pharmaceuticals, Inc., Indivor Plc, Dr. Reddy's Labarotories Limited, Perrigo Company Plc, and Mylan N.V. are some of the notable companies in the Europe addiction treatment market.